Home › Agammaglobulinemia
Agammaglobulinemia clinical trials recruiting in the U.S.
6 studies for Agammaglobulinemia are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07220915Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07648264Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06976476Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
RecruitingObservational study
Ages 2 to 120 · All sexes · Updated Sep 1, 2026 · NCT00001244A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT05645107IVIG vs SCIG in CIDP
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Dec 11, 2025 · NCT05584631From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.